CoChat

Drug disposition of incadronate, a new bisphosphonate, in rats with bone metastases.

USUI*, T., TANAKA, S., SONODA, T., OZAWA, Y., TERAMURA, K., NAKAMURA, E., WATANABE, T., HIGUCHI, S. · 1997 · Xenobiotica

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

1. Drug disposition of incadronate in the nude rat with bone metastases induced by A375 human melanoma cells was studied after intravenous administration. 2. The pharmacokinetics of incadronate (plasma concentration, urinary excretion and bone uptake) in rat with bone metastases was not markedly different from that in the control rat. This compound, however, was selectively taken up in the bone region around metastatic tumour nests. 3. Drug concentrations in the bone region around tumour nests were 3-10 micrograms/g, these levels being higher than the IC50 (0.35 microgram/ml) for the inhibitory effect of this drug on osteoclasts in vitro. 4. In contrast, concentrations in the tumour nest itself was < 0.7 microgram/g, being markedly lower than the IC50 (35 micrograms/ml) for the inhibitory effect on the proliferation of tumour cells in vitro. 5. These results strongly suggest that pharmacological action of incadronate in mouse with bone metastases (inhibitory effect on the growth of metastatic tumour in bone) is caused not by the direct action on the tumour cells but by the distribution of the drug in the perifocal bone region followed by inhibition of the activity of osteoclasts, resulting in inhibition of the osteolytic process, which is necessary for the progress of metastatic tumour.

Overview

Integrity signals

Registry

Crossref · 10.1080/004982597240442

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 14 references

Research works printed but not linked: 5

  1. KAWAMUKI K., 1990, Journal of Bone and Mineral Research, 5, S245
  2. KUDO M., 1990, Journal of Bone and Mineral Research, 5, S166
  3. NAKAI M., 1992, Cancer Research, 52, 5395
  4. SASAKI A., 1995, Cancer Research, 55, 3551
  5. TAKAHASHI K., 1994, Clinical Report, 28, 2905

Cited by

See all 13

Metadata

Authors
USUI*, T., TANAKA, S., SONODA, T., OZAWA, Y., TERAMURA, K., NAKAMURA, E., WATANABE, T., & HIGUCHI, S.
Venue
Xenobiotica
Published
1997-01
Volume
27
Issue
5
Pages
479-487
ISSN
  • 0049-8254 (ISSN-L)
  • 1366-5928
OpenAlex
W2154858612
Cited by
13
References
14
Citations by year
2013: 1
FWCI
0.15
Type
journal article
Language
en
Open access
closed
Locations
  • Xenobiotica (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Bone health and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
incadronate, bisphosphonates, drug disposition, pharmacokinetics, bone metastasis, A375 melanoma, osteoclast inhibition, osteolytic bone destruction, tumor growth inhibition
MeSH terms
Animals, Autoradiography, Bone Neoplasms, Cell Division, Diphosphonates, Half-Life, Male, Melanoma, Experimental, Metabolic Clearance Rate, Neoplasm Transplantation, Rats, Nude, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug disposition of incadronate, a new bisphosphonate, in rats with bone metastases. https://app.cochat.ai/papers/10.1080/004982597240442
The paper
USUI*, T., TANAKA, S., SONODA, T., OZAWA, Y., TERAMURA, K., NAKAMURA, E., WATANABE, T., & HIGUCHI, S. (1997). Drug disposition of incadronate, a new bisphosphonate, in rats with bone metastases. Xenobiotica. https://doi.org/10.1080/004982597240442

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.